Biohaven Gross Profit 2016-2022 | BHVN
Biohaven gross profit from 2016 to 2022. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Biohaven Annual Gross Profit
(Millions of US $) |
| 2021 |
$371 |
| 2020 |
$46 |
| 2019 |
$ |
| 2018 |
$ |
| 2017 |
$ |
| 2016 |
$ |
| 2015 |
$ |
Biohaven Quarterly Gross Profit
(Millions of US $) |
| 2022-09-30 |
|
| 2022-06-30 |
$179 |
| 2022-03-31 |
$293 |
| 2021-12-31 |
$264 |
| 2021-09-30 |
|
| 2021-06-30 |
$76 |
| 2021-03-31 |
$31 |
| 2020-12-31 |
$25 |
| 2020-09-30 |
$13 |
| 2020-06-30 |
$7 |
| 2020-03-31 |
$1 |
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2019-03-31 |
|
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2018-03-31 |
|
| 2017-12-31 |
|
| 2017-09-30 |
|
| 2017-06-30 |
|
| 2017-03-31 |
|
| 2016-12-31 |
|
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
|
| 2015-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.913B |
$0.463B |
|
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
|
